Cargando…

Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study

OBJECTIVE: Preliminary data indicate that predominant positive symptoms are predictive of subsequent treatment response, while negative and cognitive symptoms are associated with poor outcome. Purpose of the present study was to investigate the relation between the predominant clinical dimension, du...

Descripción completa

Detalles Bibliográficos
Autores principales: Buoli, Massimiliano, Caldiroli, Alice, Panza, Gabriele, Altamura, Alfredo Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521111/
https://www.ncbi.nlm.nih.gov/pubmed/23251199
http://dx.doi.org/10.4306/pi.2012.9.4.354
_version_ 1782252890241368064
author Buoli, Massimiliano
Caldiroli, Alice
Panza, Gabriele
Altamura, Alfredo Carlo
author_facet Buoli, Massimiliano
Caldiroli, Alice
Panza, Gabriele
Altamura, Alfredo Carlo
author_sort Buoli, Massimiliano
collection PubMed
description OBJECTIVE: Preliminary data indicate that predominant positive symptoms are predictive of subsequent treatment response, while negative and cognitive symptoms are associated with poor outcome. Purpose of the present study was to investigate the relation between the predominant clinical dimension, duration of illness and acute antipsychotic response in a sample of schizophrenic inpatients. METHODS: Fifty-one schizophrenic inpatients, receiving an antipsychotic mono-therapy, were dimensionally assessed at the admission in the Acute Psychiatric Unit of the University of Milan. Treatment response was selected as parameter of outcome and defined as a reduction >50% of baseline total The Positive and Negative Syndrome Scale (PANSS) score. Demographic and clinical variables between responders and non-responders were compared using one-way analysis of variance for continuous variables and χ(2) test for dichotomous ones. Binary logistic regression was performed to find if dimensional scores and duration of illness were associated with acute antipsychotic response. RESULTS: A longer duration of illness was found in non-responders respect to responders (15.61 years vs. 8.28 years)(F=4.98, p=0.03). Higher scores on PANSS positive sub-scale (OR=1.3, p=0.03), lower scores on cognitive PANSS scores (OR=0.75, p=0.05) and shorter duration of illness (OR=0.93, p=0.04) were found to be predictive of acute antipsychotic response. CONCLUSION: These preliminary results show that a long duration of illness as well as a more severe cognitive impairment is predictive of treatment non-response, indicating a worse outcome for chronic patients with predominant cognitive symptoms.
format Online
Article
Text
id pubmed-3521111
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Korean Neuropsychiatric Association
record_format MEDLINE/PubMed
spelling pubmed-35211112012-12-18 Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study Buoli, Massimiliano Caldiroli, Alice Panza, Gabriele Altamura, Alfredo Carlo Psychiatry Investig Original Article OBJECTIVE: Preliminary data indicate that predominant positive symptoms are predictive of subsequent treatment response, while negative and cognitive symptoms are associated with poor outcome. Purpose of the present study was to investigate the relation between the predominant clinical dimension, duration of illness and acute antipsychotic response in a sample of schizophrenic inpatients. METHODS: Fifty-one schizophrenic inpatients, receiving an antipsychotic mono-therapy, were dimensionally assessed at the admission in the Acute Psychiatric Unit of the University of Milan. Treatment response was selected as parameter of outcome and defined as a reduction >50% of baseline total The Positive and Negative Syndrome Scale (PANSS) score. Demographic and clinical variables between responders and non-responders were compared using one-way analysis of variance for continuous variables and χ(2) test for dichotomous ones. Binary logistic regression was performed to find if dimensional scores and duration of illness were associated with acute antipsychotic response. RESULTS: A longer duration of illness was found in non-responders respect to responders (15.61 years vs. 8.28 years)(F=4.98, p=0.03). Higher scores on PANSS positive sub-scale (OR=1.3, p=0.03), lower scores on cognitive PANSS scores (OR=0.75, p=0.05) and shorter duration of illness (OR=0.93, p=0.04) were found to be predictive of acute antipsychotic response. CONCLUSION: These preliminary results show that a long duration of illness as well as a more severe cognitive impairment is predictive of treatment non-response, indicating a worse outcome for chronic patients with predominant cognitive symptoms. Korean Neuropsychiatric Association 2012-12 2012-11-14 /pmc/articles/PMC3521111/ /pubmed/23251199 http://dx.doi.org/10.4306/pi.2012.9.4.354 Text en Copyright © 2012 Korean Neuropsychiatric Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Buoli, Massimiliano
Caldiroli, Alice
Panza, Gabriele
Altamura, Alfredo Carlo
Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
title Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
title_full Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
title_fullStr Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
title_full_unstemmed Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
title_short Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
title_sort prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521111/
https://www.ncbi.nlm.nih.gov/pubmed/23251199
http://dx.doi.org/10.4306/pi.2012.9.4.354
work_keys_str_mv AT buolimassimiliano prominentclinicaldimensiondurationofillnessandtreatmentresponseinschizophreniaanaturalisticstudy
AT caldirolialice prominentclinicaldimensiondurationofillnessandtreatmentresponseinschizophreniaanaturalisticstudy
AT panzagabriele prominentclinicaldimensiondurationofillnessandtreatmentresponseinschizophreniaanaturalisticstudy
AT altamuraalfredocarlo prominentclinicaldimensiondurationofillnessandtreatmentresponseinschizophreniaanaturalisticstudy